1 Introduction to Research & Analysis Reports
    1.1 IBS-C Drugs Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global IBS-C Drugs Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global IBS-C Drugs Overall Market Size
    2.1 Global IBS-C Drugs Market Size: 2021 VS 2028
    2.2 Global IBS-C Drugs Revenue, Prospects & Forecasts: 2017-2028
    2.3 Global IBS-C Drugs Sales: 2017-2028
3 Company Landscape
    3.1 Top IBS-C Drugs Players in Global Market
    3.2 Top Global IBS-C Drugs Companies Ranked by Revenue
    3.3 Global IBS-C Drugs Revenue by Companies
    3.4 Global IBS-C Drugs Sales by Companies
    3.5 Global IBS-C Drugs Price by Manufacturer (2017-2022)
    3.6 Top 3 and Top 5 IBS-C Drugs Companies in Global Market, by Revenue in 2021
    3.7 Global Manufacturers IBS-C Drugs Product Type
    3.8 Tier 1, Tier 2 and Tier 3 IBS-C Drugs Players in Global Market
        3.8.1 List of Global Tier 1 IBS-C Drugs Companies
        3.8.2 List of Global Tier 2 and Tier 3 IBS-C Drugs Companies
4 Sights by Product
    4.1 Overview
        4.1.1 By Type - Global IBS-C Drugs Market Size Markets, 2021 & 2028
        4.1.2 Linaclotide
        4.1.3 Lubiprostone
        4.1.4 Osmotic Laxatives
        4.1.5 Stimulant Laxatives
        4.1.6 Others
    4.2 By Type - Global IBS-C Drugs Revenue & Forecasts
        4.2.1 By Type - Global IBS-C Drugs Revenue, 2017-2022
        4.2.2 By Type - Global IBS-C Drugs Revenue, 2023-2028
        4.2.3 By Type - Global IBS-C Drugs Revenue Market Share, 2017-2028
    4.3 By Type - Global IBS-C Drugs Sales & Forecasts
        4.3.1 By Type - Global IBS-C Drugs Sales, 2017-2022
        4.3.2 By Type - Global IBS-C Drugs Sales, 2023-2028
        4.3.3 By Type - Global IBS-C Drugs Sales Market Share, 2017-2028
    4.4 By Type - Global IBS-C Drugs Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
    5.1 Overview
        5.1.1 By Application - Global IBS-C Drugs Market Size, 2021 & 2028
        5.1.2 Hospital Pharmacies
        5.1.3 Retail Pharmacies
        5.1.4 Online Pharmacies
    5.2 By Application - Global IBS-C Drugs Revenue & Forecasts
        5.2.1 By Application - Global IBS-C Drugs Revenue, 2017-2022
        5.2.2 By Application - Global IBS-C Drugs Revenue, 2023-2028
        5.2.3 By Application - Global IBS-C Drugs Revenue Market Share, 2017-2028
    5.3 By Application - Global IBS-C Drugs Sales & Forecasts
        5.3.1 By Application - Global IBS-C Drugs Sales, 2017-2022
        5.3.2 By Application - Global IBS-C Drugs Sales, 2023-2028
        5.3.3 By Application - Global IBS-C Drugs Sales Market Share, 2017-2028
    5.4 By Application - Global IBS-C Drugs Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
    6.1 By Region - Global IBS-C Drugs Market Size, 2021 & 2028
    6.2 By Region - Global IBS-C Drugs Revenue & Forecasts
        6.2.1 By Region - Global IBS-C Drugs Revenue, 2017-2022
        6.2.2 By Region - Global IBS-C Drugs Revenue, 2023-2028
        6.2.3 By Region - Global IBS-C Drugs Revenue Market Share, 2017-2028
    6.3 By Region - Global IBS-C Drugs Sales & Forecasts
        6.3.1 By Region - Global IBS-C Drugs Sales, 2017-2022
        6.3.2 By Region - Global IBS-C Drugs Sales, 2023-2028
        6.3.3 By Region - Global IBS-C Drugs Sales Market Share, 2017-2028
    6.4 North America
        6.4.1 By Country - North America IBS-C Drugs Revenue, 2017-2028
        6.4.2 By Country - North America IBS-C Drugs Sales, 2017-2028
        6.4.3 US IBS-C Drugs Market Size, 2017-2028
        6.4.4 Canada IBS-C Drugs Market Size, 2017-2028
        6.4.5 Mexico IBS-C Drugs Market Size, 2017-2028
    6.5 Europe
        6.5.1 By Country - Europe IBS-C Drugs Revenue, 2017-2028
        6.5.2 By Country - Europe IBS-C Drugs Sales, 2017-2028
        6.5.3 Germany IBS-C Drugs Market Size, 2017-2028
        6.5.4 France IBS-C Drugs Market Size, 2017-2028
        6.5.5 U.K. IBS-C Drugs Market Size, 2017-2028
        6.5.6 Italy IBS-C Drugs Market Size, 2017-2028
        6.5.7 Russia IBS-C Drugs Market Size, 2017-2028
        6.5.8 Nordic Countries IBS-C Drugs Market Size, 2017-2028
        6.5.9 Benelux IBS-C Drugs Market Size, 2017-2028
    6.6 Asia
        6.6.1 By Region - Asia IBS-C Drugs Revenue, 2017-2028
        6.6.2 By Region - Asia IBS-C Drugs Sales, 2017-2028
        6.6.3 China IBS-C Drugs Market Size, 2017-2028
        6.6.4 Japan IBS-C Drugs Market Size, 2017-2028
        6.6.5 South Korea IBS-C Drugs Market Size, 2017-2028
        6.6.6 Southeast Asia IBS-C Drugs Market Size, 2017-2028
        6.6.7 India IBS-C Drugs Market Size, 2017-2028
    6.7 South America
        6.7.1 By Country - South America IBS-C Drugs Revenue, 2017-2028
        6.7.2 By Country - South America IBS-C Drugs Sales, 2017-2028
        6.7.3 Brazil IBS-C Drugs Market Size, 2017-2028
        6.7.4 Argentina IBS-C Drugs Market Size, 2017-2028
    6.8 Middle East & Africa
        6.8.1 By Country - Middle East & Africa IBS-C Drugs Revenue, 2017-2028
        6.8.2 By Country - Middle East & Africa IBS-C Drugs Sales, 2017-2028
        6.8.3 Turkey IBS-C Drugs Market Size, 2017-2028
        6.8.4 Israel IBS-C Drugs Market Size, 2017-2028
        6.8.5 Saudi Arabia IBS-C Drugs Market Size, 2017-2028
        6.8.6 UAE IBS-C Drugs Market Size, 2017-2028
7 Manufacturers & Brands Profiles
    7.1 Catalent Pharmaceuticals Solutions
        7.1.1 Catalent Pharmaceuticals Solutions Corporate Summary
        7.1.2 Catalent Pharmaceuticals Solutions Business Overview
        7.1.3 Catalent Pharmaceuticals Solutions IBS-C Drugs Major Product Offerings
        7.1.4 Catalent Pharmaceuticals Solutions IBS-C Drugs Sales and Revenue in Global (2017-2022)
        7.1.5 Catalent Pharmaceuticals Solutions Key News
    7.2 Nestle
        7.2.1 Nestle Corporate Summary
        7.2.2 Nestle Business Overview
        7.2.3 Nestle IBS-C Drugs Major Product Offerings
        7.2.4 Nestle IBS-C Drugs Sales and Revenue in Global (2017-2022)
        7.2.5 Nestle Key News
    7.3 Abbott Laboratories
        7.3.1 Abbott Laboratories Corporate Summary
        7.3.2 Abbott Laboratories Business Overview
        7.3.3 Abbott Laboratories IBS-C Drugs Major Product Offerings
        7.3.4 Abbott Laboratories IBS-C Drugs Sales and Revenue in Global (2017-2022)
        7.3.5 Abbott Laboratories Key News
    7.4 Synergy Pharmaceuticals
        7.4.1 Synergy Pharmaceuticals Corporate Summary
        7.4.2 Synergy Pharmaceuticals Business Overview
        7.4.3 Synergy Pharmaceuticals IBS-C Drugs Major Product Offerings
        7.4.4 Synergy Pharmaceuticals IBS-C Drugs Sales and Revenue in Global (2017-2022)
        7.4.5 Synergy Pharmaceuticals Key News
    7.5 Sucampo Pharmaceuticals
        7.5.1 Sucampo Pharmaceuticals Corporate Summary
        7.5.2 Sucampo Pharmaceuticals Business Overview
        7.5.3 Sucampo Pharmaceuticals IBS-C Drugs Major Product Offerings
        7.5.4 Sucampo Pharmaceuticals IBS-C Drugs Sales and Revenue in Global (2017-2022)
        7.5.5 Sucampo Pharmaceuticals Key News
    7.6 Novartis Pharma Ag
        7.6.1 Novartis Pharma Ag Corporate Summary
        7.6.2 Novartis Pharma Ag Business Overview
        7.6.3 Novartis Pharma Ag IBS-C Drugs Major Product Offerings
        7.6.4 Novartis Pharma Ag IBS-C Drugs Sales and Revenue in Global (2017-2022)
        7.6.5 Novartis Pharma Ag Key News
    7.7 Astellas Pharmaceuticals
        7.7.1 Astellas Pharmaceuticals Corporate Summary
        7.7.2 Astellas Pharmaceuticals Business Overview
        7.7.3 Astellas Pharmaceuticals IBS-C Drugs Major Product Offerings
        7.7.4 Astellas Pharmaceuticals IBS-C Drugs Sales and Revenue in Global (2017-2022)
        7.7.5 Astellas Pharmaceuticals Key News
    7.8 Ardelyx, Inc
        7.8.1 Ardelyx, Inc Corporate Summary
        7.8.2 Ardelyx, Inc Business Overview
        7.8.3 Ardelyx, Inc IBS-C Drugs Major Product Offerings
        7.8.4 Ardelyx, Inc IBS-C Drugs Sales and Revenue in Global (2017-2022)
        7.8.5 Ardelyx, Inc Key News
    7.9 Synthetic Biologics, Inc
        7.9.1 Synthetic Biologics, Inc Corporate Summary
        7.9.2 Synthetic Biologics, Inc Business Overview
        7.9.3 Synthetic Biologics, Inc IBS-C Drugs Major Product Offerings
        7.9.4 Synthetic Biologics, Inc IBS-C Drugs Sales and Revenue in Global (2017-2022)
        7.9.5 Synthetic Biologics, Inc Key News
    7.10 Teva Pharmaceutical Industries
        7.10.1 Teva Pharmaceutical Industries Corporate Summary
        7.10.2 Teva Pharmaceutical Industries Business Overview
        7.10.3 Teva Pharmaceutical Industries IBS-C Drugs Major Product Offerings
        7.10.4 Teva Pharmaceutical Industries IBS-C Drugs Sales and Revenue in Global (2017-2022)
        7.10.5 Teva Pharmaceutical Industries Key News
    7.11 Bama-Geve, SLU
        7.11.1 Bama-Geve, SLU Corporate Summary
        7.11.2 Bama-Geve, SLU IBS-C Drugs Business Overview
        7.11.3 Bama-Geve, SLU IBS-C Drugs Major Product Offerings
        7.11.4 Bama-Geve, SLU IBS-C Drugs Sales and Revenue in Global (2017-2022)
        7.11.5 Bama-Geve, SLU Key News
    7.12 Ferring BV
        7.12.1 Ferring BV Corporate Summary
        7.12.2 Ferring BV IBS-C Drugs Business Overview
        7.12.3 Ferring BV IBS-C Drugs Major Product Offerings
        7.12.4 Ferring BV IBS-C Drugs Sales and Revenue in Global (2017-2022)
        7.12.5 Ferring BV Key News
    7.13 Ironwood Pharmaceuticals, Inc
        7.13.1 Ironwood Pharmaceuticals, Inc Corporate Summary
        7.13.2 Ironwood Pharmaceuticals, Inc IBS-C Drugs Business Overview
        7.13.3 Ironwood Pharmaceuticals, Inc IBS-C Drugs Major Product Offerings
        7.13.4 Ironwood Pharmaceuticals, Inc IBS-C Drugs Sales and Revenue in Global (2017-2022)
        7.13.5 Ironwood Pharmaceuticals, Inc Key News
    7.14 Salix Pharmaceuticals Ltd
        7.14.1 Salix Pharmaceuticals Ltd Corporate Summary
        7.14.2 Salix Pharmaceuticals Ltd Business Overview
        7.14.3 Salix Pharmaceuticals Ltd IBS-C Drugs Major Product Offerings
        7.14.4 Salix Pharmaceuticals Ltd IBS-C Drugs Sales and Revenue in Global (2017-2022)
        7.14.5 Salix Pharmaceuticals Ltd Key News
    7.15 Norgine B.V
        7.15.1 Norgine B.V Corporate Summary
        7.15.2 Norgine B.V Business Overview
        7.15.3 Norgine B.V IBS-C Drugs Major Product Offerings
        7.15.4 Norgine B.V IBS-C Drugs Sales and Revenue in Global (2017-2022)
        7.15.5 Norgine B.V Key News
    7.16 Prometheus Laboratories Inc
        7.16.1 Prometheus Laboratories Inc Corporate Summary
        7.16.2 Prometheus Laboratories Inc Business Overview
        7.16.3 Prometheus Laboratories Inc IBS-C Drugs Major Product Offerings
        7.16.4 Prometheus Laboratories Inc IBS-C Drugs Sales and Revenue in Global (2017-2022)
        7.16.5 Prometheus Laboratories Inc Key News
    7.17 Actavis Nordic A/S
        7.17.1 Actavis Nordic A/S Corporate Summary
        7.17.2 Actavis Nordic A/S Business Overview
        7.17.3 Actavis Nordic A/S IBS-C Drugs Major Product Offerings
        7.17.4 Actavis Nordic A/S IBS-C Drugs Sales and Revenue in Global (2017-2022)
        7.17.5 Actavis Nordic A/S Key News
    7.18 Albireo Pharma Inc
        7.18.1 Albireo Pharma Inc Corporate Summary
        7.18.2 Albireo Pharma Inc Business Overview
        7.18.3 Albireo Pharma Inc IBS-C Drugs Major Product Offerings
        7.18.4 Albireo Pharma Inc IBS-C Drugs Sales and Revenue in Global (2017-2022)
        7.18.5 Albireo Pharma Inc Key News
    7.19 Yuhan Corp
        7.19.1 Yuhan Corp Corporate Summary
        7.19.2 Yuhan Corp Business Overview
        7.19.3 Yuhan Corp IBS-C Drugs Major Product Offerings
        7.19.4 Yuhan Corp IBS-C Drugs Sales and Revenue in Global (2017-2022)
        7.19.5 Yuhan Corp Key News
    7.20 Astrazeneca Plc
        7.20.1 Astrazeneca Plc Corporate Summary
        7.20.2 Astrazeneca Plc Business Overview
        7.20.3 Astrazeneca Plc IBS-C Drugs Major Product Offerings
        7.20.4 Astrazeneca Plc IBS-C Drugs Sales and Revenue in Global (2017-2022)
        7.20.5 Astrazeneca Plc Key News
    7.21 The Menarini Group
        7.21.1 The Menarini Group Corporate Summary
        7.21.2 The Menarini Group Business Overview
        7.21.3 The Menarini Group IBS-C Drugs Major Product Offerings
        7.21.4 The Menarini Group IBS-C Drugs Sales and Revenue in Global (2017-2022)
        7.21.5 The Menarini Group Key News
    7.22 Ono Pharmaceutical Co., Ltd
        7.22.1 Ono Pharmaceutical Co., Ltd Corporate Summary
        7.22.2 Ono Pharmaceutical Co., Ltd Business Overview
        7.22.3 Ono Pharmaceutical Co., Ltd IBS-C Drugs Major Product Offerings
        7.22.4 Ono Pharmaceutical Co., Ltd IBS-C Drugs Sales and Revenue in Global (2017-2022)
        7.22.5 Ono Pharmaceutical Co., Ltd Key News
8 Global IBS-C Drugs Production Capacity, Analysis
    8.1 Global IBS-C Drugs Production Capacity, 2017-2028
    8.2 IBS-C Drugs Production Capacity of Key Manufacturers in Global Market
    8.3 Global IBS-C Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
    9.1 Market Opportunities & Trends
    9.2 Market Drivers
    9.3 Market Restraints
10 IBS-C Drugs Supply Chain Analysis
    10.1 IBS-C Drugs Industry Value Chain
    10.2 IBS-C Drugs Upstream Market
    10.3 IBS-C Drugs Downstream and Clients
    10.4 Marketing Channels Analysis
        10.4.1 Marketing Channels
        10.4.2 IBS-C Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
    12.1 Note
    12.2 Examples of Clients
    12.3 Disclaimer